Oncopeptides
ONCO | ST
Overview
Corporate Details
- ISIN(s):
- SE0009414576 (+4 more)
- LEI:
- 549300J9WWQ5CBYQ1M77
- Country:
- Sweden
- Address:
- Luntmakargatan 46, 111 37 Stockholm
- Website:
- https://www.oncopeptides.com/en
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Oncopeptides is a global biotech company focused on the development of targeted therapies for difficult-to-treat hematological diseases. The company is science driven and is committed to bringing innovation to patients with an unmet need and improving patient quality of life. Oncopeptides uses its proprietary Peptide Drug Candidate platform, PDC, to develop compounds that rapidly and selectively deliver cytotoxic agents into cancer cells. The headquarters is in Stockholm, Sweden, and a modern pre-clinical drug development facility in Solna, outside Stockholm, Sweden.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Oncopeptides.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-13 10:32 |
Major Shareholding Notification
|
Swedish | 10.6 KB | |
| 2025-08-07 10:08 |
Major Shareholding Notification
|
Swedish | 10.5 KB | |
| 2025-08-05 16:06 |
Major Shareholding Notification
|
Swedish | 10.4 KB | |
| 2025-07-22 10:06 |
Major Shareholding Notification
|
Swedish | 10.3 KB | |
| 2025-07-18 11:39 |
Major Shareholding Notification
|
Swedish | 10.3 KB | |
| 2025-07-14 13:43 |
Major Shareholding Notification
|
Swedish | 10.3 KB | |
| 2025-07-09 11:30 |
Earnings Release
Oncopeptides announces net sales for Q2 2025
|
English | 76.9 KB | |
| 2025-07-09 11:30 |
Earnings Release
Oncopeptides offentliggör försäljning för andra kvartalet 2025
|
Swedish | 77.7 KB | |
| 2025-05-22 14:00 |
Post-Annual General Meeting Information
Kommuniké från årsstämma i Oncopeptides AB (publ)
|
Swedish | 72.0 KB | |
| 2025-05-22 14:00 |
Post-Annual General Meeting Information
Bulletin from the Annual General Meeting in Oncopeptides AB (publ)
|
English | 72.2 KB | |
| 2025-05-15 08:00 |
Quarterly Report
|
Swedish | 517.8 KB | |
| 2025-05-15 08:00 |
Quarterly Report
|
English | 486.8 KB | |
| 2025-04-28 15:30 |
Annual Report (ESEF)
|
Swedish | 6.6 MB | |
| 2025-04-22 12:14 |
Major Shareholding Notification
|
Swedish | 8.7 KB | |
| 2025-03-03 15:26 |
Major Shareholding Notification
|
Swedish | 7.8 KB |
Automate Your Workflow. Get a real-time feed of all Oncopeptides filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Oncopeptides via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-04-15 | David Augustsson | Other | Buy | 1,250 | 6,350.00 SEK |
| 2024-04-15 | David Augustsson | Other | Buy | 1,250 | 6,312.50 SEK |
| 2024-04-15 | David Augustsson | Other | Buy | 438 | 2,225.04 SEK |
| 2024-04-15 | David Augustsson | Other | Buy | 60 | 303.60 SEK |
| 2024-04-15 | David Augustsson | Other | Buy | 2 | 10.02 SEK |
| 2023-09-08 | David Augustsson | Other | Buy | 2,296 | 17,706.75 SEK |
| 2023-08-10 | David Augustsson | Other | Buy | 1,704 | 14,995.20 SEK |
| 2023-05-04 | Nicolaas Bakker | Other | Buy | 5,000 | 42,380.00 SEK |
| 2022-10-10 | Nicolaas Bakker | Other | Buy | 15,000 | 164,400.00 SEK |
| 2022-08-30 | Per Wold-Olsen | Other | Buy | 2,050 | 55,350.00 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
BioPorto | Denmark | BIOPOR | |
|
BioSenic SA | Belgium | BIOS | |
|
Biosergen AB | Sweden | BIOSGN | |
|
BIOTECH | Spain | BST | |
|
Biotest AG | Germany | BIO3 | |
|
Bioton S.A. | Poland | BIO | |
|
Bioversys N | Switzerland | BIOV | |
|
Biovica International B | Sweden | BIOVIC | |
|
Bonus BioGroup Ltd. | Israel | BONS | |
|
BRAIN Biotech AG | Germany | BNN |